Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimized vs Standard Amoxicillin for H. Pylori
NCT05635942Phase 4Completed
- Sponsor
- Les Laboratoires des Médicaments Stériles
- Start
- Jan 2019
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amoxicillin in Helicobacter pylori infection (2 arms), sponsored by Les Laboratoires des Médicaments Stériles. Primary endpoint: Helicobacter Pylori eradication rate. Started Jan 2019; status: completed.
02
Drugs
amoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05635942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05635942.